Glenmark 'pioneers' Mitsubishi's teneligliptin in India
This article was originally published in Scrip
Executive Summary
Brace yourselves for a potential upsurge in action – both in price and probably elsewhere - in the dipeptidyl peptidase-4 (DPP-4) inhibitor segment in India.